Literature DB >> 25382184

Retinal damage and vision loss in African American multiple sclerosis patients.

Dorlan J Kimbrough1, Elias S Sotirchos, James A Wilson, Omar Al-Louzi, Amy Conger, Darrel Conger, Teresa C Frohman, Shiv Saidha, Ari J Green, Elliot M Frohman, Laura J Balcer, Peter A Calabresi.   

Abstract

OBJECTIVE: To determine whether African American (AA) multiple sclerosis (MS) patients exhibit more retinal damage and visual impairment compared to Caucasian American (CA) MS patients.
METHODS: A total of 687 MS patients (81 AAs) and 110 healthy control (HC) subjects (14 AAs) were recruited at 3 academic hospitals between 2008 and 2012. Using mixed effects regression models, we compared high- and low-contrast visual acuity (HCVA and LCVA) and high-definition spectral domain optical coherence tomography measures of retinal architecture between MS patients of self-identified AA and CA ancestry.
RESULTS: In HCs, baseline peripapillary retinal nerve fiber layer (RNFL) thickness was 6.1µm greater in AAs (p = 0.047), whereas ganglion cell/inner plexiform layer (GCIP) thickness did not differ by race. In MS patients, baseline RNFL did not differ by race, and GCIP was 3.98µm thinner in AAs (p = 0.004). AAs had faster RNFL and GCIP thinning rates compared to CAs (p = 0.004 and p = 0.046, respectively). AA MS patients had lower baseline HCVA (p = 0.02) and worse LCVA per year of disease duration (p = 0.039). Among patients with an acute optic neuritis (AON) history, AAs had greater loss of HCVA than CA patients (p = 0.012).
INTERPRETATION: This multicenter investigation provides objective evidence that AA MS patients exhibit accelerated retinal damage compared to CA MS patients. Self-identified AA ancestry is associated with worse MS-related visual disability, particularly in the context of an AON history, suggesting a more aggressive inflammatory disease course among AA MS patients or a subpopulation therein.
© 2014 American Neurological Association.

Entities:  

Mesh:

Year:  2015        PMID: 25382184      PMCID: PMC4315746          DOI: 10.1002/ana.24308

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

1.  Optic neuritis in African Americans.

Authors:  P H Phillips; N J Newman; M J Lynn
Journal:  Arch Neurol       Date:  1998-02

2.  Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution.

Authors:  J F Kurtzke; G W Beebe; J E Norman
Journal:  Neurology       Date:  1979-09       Impact factor: 9.910

Review 3.  The epidemiology of multiple sclerosis: a general overview.

Authors:  C M Poser
Journal:  Ann Neurol       Date:  1994-12       Impact factor: 10.422

4.  Vitamin D in African Americans with multiple sclerosis.

Authors:  J M Gelfand; B A C Cree; J McElroy; J Oksenberg; R Green; E M Mowry; J W Miller; S L Hauser; A J Green
Journal:  Neurology       Date:  2011-05-24       Impact factor: 9.910

5.  Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS.

Authors:  J F Kurtzke; W F Page
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1991-12

7.  Vitamin D intake and incidence of multiple sclerosis.

Authors:  K L Munger; S M Zhang; E O'Reilly; M A Hernán; M J Olek; W C Willett; A Ascherio
Journal:  Neurology       Date:  2004-01-13       Impact factor: 9.910

8.  [Multiple sclerosis in the black population].

Authors:  C M Poser; J C Vernant
Journal:  Bull Soc Pathol Exot       Date:  1993

9.  Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.

Authors:  B Weinstock-Guttman; L D Jacobs; C M Brownscheidle; M Baier; D F Rea; B R Apatoff; K M Blitz; P K Coyle; A T Frontera; A D Goodman; M H Gottesman; J Herbert; R Holub; N S Lava; M Lenihan; J Lusins; C Mihai; A E Miller; A B Perel; D H Snyder; R Bakshi; C V Granger; S J Greenberg; B Jubelt; L Krupp; F E Munschauer; D Rubin; S Schwid; J Smiroldo
Journal:  Mult Scler       Date:  2003-06       Impact factor: 6.312

10.  Primary and transitional progressive MS: a clinical and MRI cross-sectional study.

Authors:  V L Stevenson; D H Miller; M Rovaris; F Barkhof; B Brochet; V Dousset; V Dousset; M Filippi; X Montalban; C H Polman; A Rovira; J de Sa; A J Thompson
Journal:  Neurology       Date:  1999-03-10       Impact factor: 9.910

View more
  26 in total

1.  Spinal cord and infratentorial lesions in radiologically isolated syndrome are associated with decreased retinal ganglion cell/inner plexiform layer thickness.

Authors:  Angeliki Filippatou; Thomas Shoemaker; Megan Esch; Madiha Qutab; Natalia Gonzalez-Caldito; Jerry L Prince; Ellen M Mowry; Peter A Calabresi; Shiv Saidha; Elias S Sotirchos
Journal:  Mult Scler       Date:  2018-12-03       Impact factor: 6.312

2.  An ImmunoChip study of multiple sclerosis risk in African Americans.

Authors:  Noriko Isobe; Lohith Madireddy; Pouya Khankhanian; Takuya Matsushita; Stacy J Caillier; Jayaji M Moré; Pierre-Antoine Gourraud; Jacob L McCauley; Ashley H Beecham; Laura Piccio; Joseph Herbert; Omar Khan; Jeffrey Cohen; Lael Stone; Adam Santaniello; Bruce A C Cree; Suna Onengut-Gumuscu; Stephen S Rich; Stephen L Hauser; Stephen Sawcer; Jorge R Oksenberg
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

3.  Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.

Authors:  Julia Button; Omar Al-Louzi; Andrew Lang; Pavan Bhargava; Scott D Newsome; Teresa Frohman; Laura J Balcer; Elliot M Frohman; Jerry Prince; Peter A Calabresi; Shiv Saidha
Journal:  Neurology       Date:  2017-01-11       Impact factor: 9.910

4.  Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.

Authors:  Magí Andorrà; Salut Alba-Arbalat; Anna Camos-Carreras; Iñigo Gabilondo; Elena Fraga-Pumar; Ruben Torres-Torres; Irene Pulido-Valdeolivas; Ana I Tercero-Uribe; Ana M Guerrero-Zamora; Santiago Ortiz-Perez; Irati Zubizarreta; Nuria Sola-Valls; Sara Llufriu; Maria Sepulveda; Eugenia Martinez-Hernandez; Thais Armangue; Yolanda Blanco; Pablo Villoslada; Bernardo Sanchez-Dalmau; Albert Saiz; Elena H Martinez-Lapiscina
Journal:  JAMA Neurol       Date:  2020-02-01       Impact factor: 18.302

5.  Characteristics of morphologic macular abnormalities in neuroimmunology practice.

Authors:  Omar Al-Louzi; Elias S Sotirchos; Angela Vidal-Jordana; Shin C Beh; Julia Button; Howard S Ying; Laura J Balcer; Elliot M Frohman; Shiv Saidha; Peter A Calabresi; Scott D Newsome
Journal:  Mult Scler       Date:  2017-11-10       Impact factor: 6.312

6.  Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Authors:  Natalia Gonzalez Caldito; Shiv Saidha; Elias S Sotirchos; Blake E Dewey; Norah J Cowley; Jeffrey Glaister; Kathryn C Fitzgerald; Omar Al-Louzi; James Nguyen; Alissa Rothman; Esther Ogbuokiri; Nicholas Fioravante; Sydney Feldman; Ohemaa Kwakyi; Hunter Risher; Dorlan Kimbrough; Teresa C Frohman; Elliot Frohman; Laura Balcer; Ciprian Crainiceanu; Peter C M Van Zijl; Ellen M Mowry; Daniel S Reich; Jiwon Oh; Dzung L Pham; Jerry Prince; Peter A Calabresi
Journal:  Brain       Date:  2018-11-01       Impact factor: 13.501

7.  Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis.

Authors:  Eleni S Vasileiou; Angeliki G Filippatou; Daniela Pimentel Maldonado; Grigorios Kalaitzidis; Henrik Ehrhardt; Jeffrey Lambe; Shiv Saidha; Elias S Sotirchos; Ellen M Mowry; Peter A Calabresi; Kathryn C Fitzgerald
Journal:  Brain       Date:  2021-12-31       Impact factor: 13.501

Review 8.  Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis.

Authors:  Josefine Britze; Gorm Pihl-Jensen; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2017-05-31       Impact factor: 4.849

Review 9.  Race and ethnicity on MS presentation and disease course.

Authors:  Lilyana Amezcua; Jacob L McCauley
Journal:  Mult Scler       Date:  2020-01-22       Impact factor: 6.312

10.  Genetic predictors of relapse rate in pediatric MS.

Authors:  Jennifer S Graves; Lisa F Barcellos; Xiaorong Shao; Janelle Noble; Ellen M Mowry; Hong Quach; Anita Belman; T Charles Casper; Lauren B Krupp; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2016-01-14       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.